​

DaVita (DVA) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

DVA Stock Forecast

DaVita (DVA) stock forecast, based on 23 Wall Street analysts, predicts a 12-month average price target of $202.25, with a high of $220.00 and a low of $190.00. This represents a -3.07% decline from the last price of $208.66.

$100 $130 $160 $190 $220 $250 High: $220 Avg: $202.25 Low: $190 Last Closed Price: $208.66

DVA Stock Rating

DaVita stock's rating consensus is Hold, based on 23 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 9 Buy (39.13%), 13 Hold (56.52%), 1 Sell (4.35%), and 0 Strong Sell (0.00%).

Hold
Total 23 0 1 13 9 Strong Sell Sell Hold Buy Strong Buy

DVA Price Target Upside V Benchmarks

TypeNameUpside
StockDaVita-3.07%
SectorHealthcare Stocks 15.45%
IndustryMedical Care Facilities Stocks26.90%

Price Target Trends

1M3M12M
# Anlaysts-310
Avg Price Target-$206.33$170.50
Last Closing Price$208.66$208.66$208.66
Upside/Downside--1.12%-18.29%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 26-24-28
May, 26-16-18
Apr, 26-16-18
Mar, 26-16-18
Feb, 26117-110
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
May 08, 2026Truist Financial$205.00$194.395.46%-1.75%
May 07, 2026Andrew MokBarclays$194.00$193.880.06%-7.03%
May 06, 2026Pito ChickeringDeutsche Bank$220.00$157.0440.09%5.43%
Feb 05, 2026Truist Financial$158.00$144.429.40%-24.28%
Feb 04, 2026UBS$190.00$134.7341.02%-8.94%
Feb 03, 2026Barclays$158.00$111.1942.10%-24.28%
Oct 30, 2025Barclays$143.00$126.5612.99%-31.47%
Oct 14, 2025David MacDonaldTruist Financial$140.00$123.3613.49%-32.91%
Oct 09, 2025Andrew MokBarclays$149.00$127.8916.51%-28.59%
Aug 08, 2025David MacDonaldTruist Financial$148.00$129.5414.25%-29.07%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 11, 2026Cowen & Co.HoldHoldhold
May 06, 2026Deutsche BankBuyupgrade
Feb 04, 2026UBSBuyBuyhold
Feb 03, 2026Cowen & Co.HoldHoldhold
Dec 15, 2025UBSBuyBuyhold
Nov 03, 2025Cowen & Co.HoldHoldhold
May 19, 2025Cowen & Co.HoldHoldhold
Feb 18, 2025Cowen & Co.HoldHoldhold
May 06, 2024BarclaysEqual-WeightEqual-Weighthold
Jan 05, 2023CFRAHoldupgrade

Financial Forecast

EPS Forecast

$5 $8 $11 $14 $17 $20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$9.30$5.88$7.62$11.02$10.06---
Avg Forecast$8.89$6.21$7.98$9.69$11.41$13.71$15.04$16.96
High Forecast$9.04$6.25$8.10$9.76$12.05$15.54$16.82$17.41
Low Forecast$8.76$6.15$7.77$9.64$10.75$11.99$13.26$16.81
Surprise %4.61%-5.31%-4.51%13.73%-11.83%---

Revenue Forecast

$11B $12B $13B $14B $15B $16B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$11.62B$11.61B$12.14B$12.82B$13.64B---
Avg Forecast$11.59B$11.62B$12.01B$12.78B$13.33B$13.79B$14.53B$15.02B
High Forecast$11.74B$11.69B$12.04B$12.83B$13.37B$13.81B$14.61B$15.33B
Low Forecast$11.46B$11.55B$11.98B$12.74B$13.29B$13.78B$14.44B$14.92B
Surprise %0.28%-0.12%1.11%0.25%2.39%---

Net Income Forecast

$500M $800M $1B $1B $2B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$978.45M$560.40M$691.53M$936.34M$746.80M---
Avg Forecast$838.97M$839.66M$691.53M$903.84M$1.06B$1.28B$1.40B$1.58B
High Forecast$1.01B$1.01B$829.84M$909.42M$1.12B$1.45B$1.57B$1.62B
Low Forecast$671.18M$671.73M$553.23M$898.26M$1.00B$1.12B$1.24B$1.57B
Surprise %16.63%-33.26%-3.60%-29.70%---

DVA Forecast FAQ

Is DaVita stock a buy?

DaVita stock has a consensus rating of Hold, based on 23 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 9 Buy, 13 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that DaVita is a neutral investment for most analysts.

What is DaVita's price target?

DaVita's price target, set by 23 Wall Street analysts, averages $202.25 over the next 12 months. The price target range spans from $190 at the low end to $220 at the high end, suggesting a potential -3.07% change from the previous closing price of $208.66.

How does DaVita stock forecast compare to its benchmarks?

DaVita's stock forecast shows a -3.07% downside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the medical care facilities stocks industry (26.90%).

What is the breakdown of analyst ratings for DaVita over the past three months?

  • June 2026: 0% Strong Buy, 25.00% Buy, 50.00% Hold, 0% Sell, 25.00% Strong Sell.
  • May 2026: 0% Strong Buy, 12.50% Buy, 75.00% Hold, 0% Sell, 12.50% Strong Sell.
  • April 2026: 0% Strong Buy, 12.50% Buy, 75.00% Hold, 0% Sell, 12.50% Strong Sell.

What is DaVita’s EPS forecast?

DaVita's average annual EPS forecast for its fiscal year ending in December 2026 is $13.71, marking a 36.28% increase from the reported $10.06 in 2025. Estimates for the following years are $15.04 in 2027, and $16.96 in 2028.

What is DaVita’s revenue forecast?

DaVita's average annual revenue forecast for its fiscal year ending in December 2026 is $13.79B, reflecting a 1.11% increase from the reported $13.64B in 2025. The forecast for 2027 is $14.52B, and $15.02B for 2028.

What is DaVita’s net income forecast?

DaVita's net income forecast for the fiscal year ending in December 2026 stands at $1.28B, representing an 71.78% increase from the reported $746.8M in 2025. Projections indicate $1.4B in 2027, and $1.58B in 2028.